INSIGHTS ON QUALITY ASSURANCE
-
![GettyImages-1793747580-DNA-double-helix-AI]( "Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer")
Digital Biomanufacturing, Now: From Digital Dreamer To Digital DoerDiscover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
![GettyImages-1487365113-scientist-with-gloves-tablet-in-hands-microscope-lab]( "Quality Over Checkbox Compliance: From QRM To Quality Maturity")
Quality Over Checkbox Compliance: From QRM To Quality MaturityQuality maturity shifts asset management from compliance-focused to risk-based. Discover how performance-driven calibration and leading indicators create systems where quality outcomes become inevitable.
-
![GettyImages-618725044 lab, tablet, teamwork]( "Technology Transfer And The Need For Digital Transformation")
Technology Transfer And The Need For Digital TransformationThe right data management platform can streamline biopharma technology transfer by bridging digital gaps, accelerating commercialization, ensuring compliance, and reducing costs.
-
![GettyImages-1395524709-automation-robotic-production]( "MTP And \"The Ballroom Concept\": Agile Manufacturing For Pharma")
MTP And "The Ballroom Concept": Agile Manufacturing For PharmaModular automation is reshaping manufacturing by enabling faster changeovers, reduced downtime, and built‑in compliance. Learn how the “ballroom” approach helps teams adapt to shifting demand.
-
Ensuring Integrity: A Comprehensive Approach To CCI1/8/2026
Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.
-
Building Digitally Connected Packaging Operations With Open Standards1/29/2026
Connect shopfloor equipment with enterprise systems to streamline your data flow. Learn how automation standards enhance integration and see a live demonstration of unified line performance in action.
-
The Commercial Advantage Of Softgels10/8/2025
Among oral dosage forms, softgel capsules stand out as a versatile and high-performance option — offering superior delivery characteristics, consumer appeal, and brand differentiation.
-
Exploring Agentic AI In GMP Operations8/12/2025
Discover how agentic AI is poised to transform Enterprise Asset Management in regulated industries to enhance compliance, reduce downtime, and bridge fragmented systems for resilient operations.
-
Identification Of Conjugation Sites In An Antibody Drug Conjugate6/18/2026
A streamlined workflow enables confident mapping of lysine-linked conjugation sites in ADCs. See how integrated automation and high-resolution analysis simplify complex characterization challenges.
QUALITY ASSURANCE SOLUTIONS
-
![bio-manufacturing-GettyImages-2194012901]( "Custom API Manufacturing For Small Molecule And High‑Potency Programs")
Custom API manufacturing services support small molecule and high‑potency programs with flexible scales, advanced unit operations, and integrated analytical, quality, and regulatory expertise.
-
![ÄKTA oligosynt™ oligonucleotide synthesizer]( "Meet The Latest Member Of The Oligo Synthesis Family")
Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.
-
![Female researcher analyzing scientific samples-GettyImages-2231025177]( "Advance Your Lead Oligonucleotide Candidates From Discovery To Market")
Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish purity and quality.
-
![Genedata Expressionist]( "Data Processing Across Instruments, Teams, And Sites")
Streamline mass spectrometry workflows with automated, harmonized data processing that delivers faster, more consistent results. Discover how you can reduce costs and improve efficiency.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
